AI Assistant
Blog
Pricing
Log In
Sign Up
Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA
®
), a novel therapeutic agent for insomnia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
